| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 14 | |
| #2 | United States | 14 | |
| #3 | EPO (European Patent Office) | 11 | |
| #4 | Australia | 9 | |
| #5 | Canada | 7 | |
| #6 | WIPO (World Intellectual Property Organization) | 7 | |
| #7 | Brazil | 3 | |
| #8 | China | 3 | |
| #9 | Czechia | 3 | |
| #10 | Slovakia | 3 | |
| #11 | Hong Kong | 2 | |
| #12 | Hungary | 2 | |
| #13 | Republic of Korea | 2 | |
| #14 | Mexico | 2 | |
| #15 | Poland | 2 | |
| #16 | Germany | 1 | |
| #17 | Finland | 1 | |
| #18 | Israel | 1 | |
| #19 | Japan | 1 | |
| #20 | Luxembourg | 1 | |
| #21 | Netherlands | 1 | |
| #22 | New Zealand | 1 | |
| #23 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Environmental technology | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Microorganisms | |
| #3 | Peptides | |
| #4 | Therapeutic chemical compounds | |
| #5 | Climate change adaptation technologies | |
| #6 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chatfield Steven Neville | 36 |
| #2 | Dougan Gordon | 19 |
| #3 | Khan Mohammed Anjam | 19 |
| #4 | Thoma Hans A | 16 |
| #5 | Roberts Mark | 13 |
| #6 | Hormaeche Carlos Estenio | 12 |
| #7 | Li Jingli | 7 |
| #8 | Villarreal-Ramos Bernardo | 5 |
| #9 | Thoma Hans | 5 |
| #10 | Chatfield Steven N | 4 |
| Publication | Filing date | Title |
|---|---|---|
| GB9522351D0 | Vaccine compositions | |
| CN1153531A | Expression of heterologous proteins in attenuated bacteria using HTRA-promoters | |
| GB9500788D0 | Vaccine compositions | |
| AU7788194A | Vaccine compositions | |
| GB9419979D0 | Vaccine compositions | |
| GB9416097D0 | Vaccine compositions | |
| CA2168885A1 | Vaccine compositions | |
| EP0712442A1 | Vaccine compositions | |
| GB9601739D0 | DNA encoding a fusion protein comprising the C fragment of tetanus toxin | |
| GB9401787D0 | Vaccine compositions | |
| GB9401795D0 | Vaccines | |
| GB9324743D0 | Adjuvant compositions | |
| GB9320454D0 | Vaccine compositions | |
| GB9316745D0 | Vaccine compositions | |
| AU4719393A | Expression of recombinant fusion proteins in attenuated bacteria | |
| AU4267093A | Vaccine compositions for mucosal delivery | |
| GB9306398D0 | Vaccines | |
| GB9220360D0 | Vaccines | |
| GB9217154D0 | Pharmaceutical compositions and their use | |
| GB9216317D0 | Vaccines |